Skip to main navigation Skip to search Skip to main content

Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use

  • Franco Aversa
  • , Alessandro Busca
  • , Anna Candoni
  • , Simone Cesaro
  • , Corrado Girmenia
  • , Mario Luppi
  • , Anna Maria Nosari
  • , Livio Pagano
  • , Luigina Romani
  • , Giuseppe Rossi
  • , Adriano Venditti
  • , Andrea Novelli
  • University of Parma
  • Azienda Ospedaliera - Universitaria Città della Salute e della Scienza di Torino
  • Integrata
  • G.B. Rossi Hospital
  • University of Rome La Sapienza
  • University of Modena and Reggio Emilia
  • Asst Grande Ospedale Metropolitano Niguarda
  • University of Perugia
  • Spedali Civili Di Brescia
  • University of Rome Tor Vergata
  • University of Florence

Research output: Contribution to journalArticle

Abstract

not done
Original languageEnglish
Pages (from-to)131-143
Number of pages13
JournalJournal of Chemotherapy
DOIs
Publication statusPublished - 2017

Keywords

  • Antifungal activity
  • Antifungal prophylaxis
  • Immune-pharmacology
  • Invasive fungal infection
  • Liposomal amphotericin

Fingerprint

Dive into the research topics of 'Liposomal amphotericin B (AmBisome®) at beginning of its third decade of clinical use'. Together they form a unique fingerprint.

Cite this